BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation

Journal of Cancer Research and Clinical Oncology

Volumn 141, Issue 6, 2015, Pages 1013-1024

  Wang, Lin ^a   Park, Paul ^a   La Marca, Frank ^a   Than, Khoi D ^a   Lin, Chia Ying ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Aldehyde dehydrogenase; BMP 2; Cancer stem cells; Renal cell carcinoma

Indexed keywords

ALDEHYDE DEHYDROGENASE; BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN 2;

ANIMAL; BONE DEVELOPMENT; BONE NEOPLASMS; CANCER STEM CELL; CARCINOMA, RENAL CELL; CELL PROLIFERATION; CELL TRANSFORMATION; DOWN REGULATION; DRUG EFFECTS; DRUG SCREENING; ENZYMOLOGY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; KIDNEY NEOPLASMS; METABOLISM; MOUSE; NONOBESE DIABETIC MOUSE; OSTEOSARCOMA; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; TUMOR CELL LINE;

ALDEHYDE DEHYDROGENASE; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE NEOPLASMS; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASTIC STEM CELLS; OSTEOGENESIS; OSTEOSARCOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84937965099     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1883-0     Document Type: Article

References (50)

1. Le Page C et al (2009) BMP-2 signaling in ovarian cancer and its association with poor prognosis. J Ovarian Res 24. doi:10.1186/1757-2215-2-4
2. Azzi S et al (2011) Differentiation therapy: targeting human renal cancer stem cells with interleukin 15. J Natl Cancer Inst 103(24):1884–1898. doi:10.1093/jnci/djr451
3. Beck SE et al (2006) Bone morphogenetic protein signaling and growth suppression in colon cancer. Am J Physiol Gastrointest Liver Physiol 291(1):G135–G145
4. Beck RW et al (2009) The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 32(8):1378–1383. doi:10.2337/dc09-0108
5. Boonyaratanakornkit JB et al (2010) Selection of tumorigenic melanoma cells using ALDH. J Invest Dermatol 130(12):2799–2808. doi:10.1038/jid.2010.237
6. Brubaker KD, Corey E, Brown LG, Vessella RL (2004) Bone morphogenetic protein signaling in prostate cancer cell lines. J Cell Biochem 91(1):151–160. doi:10.1002/jcb.10679
7. Bussolati B, Bruno S, Grange C, Ferrando U, Camussi G (2008) Identification of a tumor-initiating stem cell population in human renal carcinomas. FASEB J 22(10):3696–3705. doi:10.1096/fj.08-102590
8. Chambers I, Tomlinson SR (2009) The transcriptional foundation of pluripotency. Development 136(14):2311–2322. doi:10.1242/dev.024398
9. Costa LJ, Drabkin HA (2007) Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies. Oncologist 12(12):1404–1415. doi:10.1634/theoncologist.12-12-1404
10. Dean M, Fojo T, Bates S (2005) Tumour stem cells and drug resistance. Nat Rev Cancer 5(4):275–284
11. Diehn M, Cho RW, Clarke MF (2009) Therapeutic implications of the cancer stem cell hypothesis. Semin Radiat Oncol 19(2):78–86. doi:10.1016/j.semradonc.2008.11.002
12. Fong S, Chan MK, Fong A, Bowers WJ, Kelly KJ (2010) Viral vector-induced expression of bone morphogenetic protein 2 produces inhibition of tumor growth and bone differentiation of stem cells. Cancer Gene Ther 17(2):80–85. doi:10.1038/cgt.2009.56
13. Gassenmaier M et al (2013) CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis. Stem Cells 31(8):1467–1476. doi:10.1002/stem.1407
14. Ghosh-Choudhury N, Woodruff K, Qi W, Celeste A, Abboud SL, Ghosh Choudhury G (2000) Bone morphogenetic protein-2 blocks MDA MB 231 human breast cancer cell proliferation by inhibiting cyclin-dependent kinase-mediated retinoblastoma protein phosphorylation. Biochem Biophys Res Commun 272(3):705–711
15. Giuffrida D, Rogers IM (2010) Targeting cancer stem cell lines as a new treatment of human cancer. Recent Pat Anticancer Drug Discov 5(3):205–218
16. Huang B et al (2013) Cancer stem cell-like side population cells in clear cell renal cell carcinoma cell line 769P. PLoS ONE 8(7):e68293. doi:10.1371/journal.pone.0068293
17. Ide H, Yoshida T, Matsumoto N, Aoki K, Osada Y, Sugimura T, Terada M (1997) Growth regulation of human prostate cancer cells by bone morphogenetic protein-2. Cancer Res 57(22):5022–5027
18. Jiang F et al (2009) Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 7(3):330–338. doi:10.1158/1541-7786.MCR-08-0393
19. Kang MH, Kim JS, Seo JE, Oh SC, Yoo YA (2010) BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3 K)/Akt pathway. Exp Cell Res 316(1):24–37. doi:10.1016/j.yexcr.2009.10.010
20. Katagiri T et al (1994) Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127(6 Pt 1):1755–1766
21. Kawamura C et al (2000) Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3. Blood 96(6):2005–2011
22. Kim RJ, Nam JS (2011) OCT4 expression enhances features of cancer stem cells in a mouse model of breast cancer. Lab Anim Res 27(2):147–152. doi:10.5625/lar.2011.27.2.147
23. Kleeff J, Maruyama H, Ishiwata T, Sawhney H, Friess H, Buchler MW, Korc M (1999) Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo. Gastroenterology 116(5):1202–1216
24. Kobayashi M, Murakami T, Uchibori R, Chun NA, Kobayashi E, Morita T, Ozawa K (2010) Establishment and characterization of transplantable, luminescence labeled rat renal cell carcinoma cell lines. J Urol 183(5):2029–2035. doi:10.1016/j.juro.2009.12.090
25. Laflamme C, Curt S, Rouabhia M (2010) Epidermal growth factor and bone morphogenetic proteins upregulate osteoblast proliferation and osteoblastic markers and inhibit bone nodule formation. Arch Oral Biol 55(9):689–701. doi:10.1016/j.archoralbio.2010.06.010
26. Langenfeld EM, Calvano SE, Abou-Nukta F, Lowry SF, Amenta P, Langenfeld J (2003) The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Carcinogenesis 24(9):1445–1454. doi:10.1093/carcin/bgg100
27. Liao WY et al (2013) Cyclohexylmethyl flavonoids suppress propagation of breast cancer stem cells via downregulation of NANOG. Evid Based Complement Alternat Med 2013:170261. doi:10.1155/2013/170261
28. Lu X, Mazur SJ, Lin T, Appella E, Xu Y (2013) The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. Oncogene Jun 17 [Epub ahead of print]. doi:10.1038/onc.2013.209
29. Ma S et al (2007) Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 132(7):2542–2556. doi:10.1053/j.gastro.2007.04.025
30. Ma S, Chan KW, Lee TK, Tang KH, Wo JY, Zheng BJ, Guan XY (2008) Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res 6(7):1146–1153. doi:10.1158/1541-7786.MCR-08-0035
31. Markic D, Celic T, Spanjol J, Grskovic A, Bobinac D, Fuckar Z (2010) Expression of bone morphogenetic protein-7, its receptors and Smad1/5/8 in normal human kidney and renal cell cancer. Coll Antropol 34(Suppl 2):149–153
32. Motzer RJ, Russo P, Nanus DM, Berg WJ (1997) Renal cell carcinoma. Curr Probl Cancer 21(4):185–232
33. Nishizawa S et al (2012) HSP DNAJB8 controls tumor-initiating ability in renal cancer stem-like cells. Cancer Res 72(11):2844–2854. doi:10.1158/0008-5472.CAN-11-3062
34. Reddi AH (2001) Bone morphogenetic proteins: from basic science to clinical applications. J Bone Joint Surg Am 83(Suppl 1, Pt 1):S1–S6
35. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63(1):11–30. doi:10.3322/caac.21166
36. Stratford EW et al (2011) Liposarcoma cells with aldefluor and CD133 activity have a cancer stem cell potential. Clin Sarcoma Res 1(1):8. doi:10.1186/2045-3329-1-8
37. Tokunaga K, Ogose A, Endo N, Nomura S, Takahashi HE (1996) Human osteosarcoma (OST) induces mouse reactive bone formation in xenograft system. Bone 19(5):447–454
38. Ueda K et al (2013) Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell line. PLoS ONE 8(10):e75463. doi:10.1371/journal.pone.0075463
39. van den Hoogen C et al (2010) High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. Cancer Res 70(12):5163–5173. doi:10.1158/0008-5472.CAN-09-3806
40. Vermeulen L, Sprick MR, Kemper K, Stassi G, Medema JP (2008) Cancer stem cells-old concepts, new insights. Cell Death Differ 15(6):947–958. doi:10.1038/cdd.2008.20
41. Wang L, Park P, Zhang H, La Marca F, Claeson A, Valdivia J, Lin CY (2011a) BMP-2 inhibits the tumorigenicity of cancer stem cells in human osteosarcoma OS99-1 cell line. Cancer Biol Ther 11(5):457–463
42. Wang L, Park P, Zhang H, La Marca F, Lin CY (2011b) Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity. Int J Cancer 128(2):294–303. doi:10.1002/ijc.25331
43. Wang L et al (2012) BMP-2 inhibits tumor growth of human renal cell carcinoma and induces bone formation. Int J Cancer 131(8):1941–1950. doi:10.1002/ijc.27444
44. Wang L, Park P, La Marca F, Than K, Rahman S, Lin CY (2013) Bone formation induced by BMP-2 in human osteosarcoma cells. Int J Oncol 43(4):1095–1102. doi:10.3892/ijo.2013.2030
45. Wen XZ, Miyake S, Akiyama Y, Yuasa Y (2004) BMP-2 modulates the proliferation and differentiation of normal and cancerous gastric cells. Biochem Biophys Res Commun 316(1):100–106. doi:10.1016/j.bbrc.2004.02.016
46. Yamasaki M, Nomura T, Mimata H, Nomura Y (2004) Involvement of bone morphogenetic protein 2 in ossification of renal cell carcinoma. J Urol 172(2):475–476. doi:10.1097/01.ju.0000130509.34235.ef
47. Yamate J, Kotera T, Kuwamura M, Kotani T (2007) Potential osteogenic differentiation of cisplatin-resistant rat malignant fibrous histiocytoma-derived cell lines. Exp Toxicol Pathol 58(5):299–309. doi:10.1016/j.etp.2006.11.008
48. Zhong Y et al (2010) Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells. Cancer Lett 299(2):150–160. doi:10.1016/j.canlet.2010.08.013
49. Zhou TB (2012) Signaling pathways of PAX2 and its role in renal interstitial fibrosis and glomerulosclerosis. J Recept Signal Transduct Res 32(6):298–303. doi:10.3109/10799893.2012.738231
50. zur Nieden NI, Kempka G, Ahr HJ (2003) In vitro differentiation of embryonic stem cells into mineralized osteoblasts. Differentiation 71(1):18–27. doi:10.1046/j.1432-0436.2003.700602.x